Ethosuximide Capsule
Product Images NDC 42806-711

2 FDA label images from Epic Pharma, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 42806-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg-100ct.jpg (Bt 250mg 60ct)

250mg-100ct.jpg (Bt 250mg 60ct)
Ethosuximide 250 mg capsules label from Epic Pharma, LLC. The label states the product name, dosage strength (250 mg), and form (capsules). It includes storage instructions, a caution to keep medication out of the reach of children, and notes the package size of 100 capsules. The label also identifies the manufacturer as Humanwell PuraCap Pharmaceutical in Wuhan, China, and provides the product NDC 42806-711-01.*
FDA Label Image

Structure-formula.jpg (Image 01)

Structure-formula.jpg (Image 01)
Chemical structure of Ethosuximide displayed as a molecular diagram, showing its ring structure with nitrogen and oxygen atoms and attached ethyl and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.